Top Markets
Coin of the day
Kyto Technology and Life Science, Inc. Kyto Technology and Life Science, Inc.

Kyto Technology and Life Science, Inc.

KBPH
Classificação em ações #34728
Kyto Technology and Life Science, Inc. operates as a venture capital firm,... Kyto Technology and Life Science, Inc. operates as a venture capital firm, primarily targeting nascent and early-stage enterprises. Its investment focus lies specifically within the technology and life science sectors. The firm's funding approach offers two main options: either secured convertible debt (which accrues interest and includes a conversion discount into preferred equity) or direct investment in preferred shares. Notably, Kyto Technology and Life Science does not take the lead role in financing rounds. Its investment capital is geographically distributed, with half allocated to ventures in the United States and the remainder supporting companies in Canada and Israel. Established in 1999, the company was formerly known as Kyto BioPharma, Inc. before rebranding in April 2018. It maintains its headquarters in Los Altos Hills, California, with a secondary office located in Scotts Valley, California.
Preço da ação
$1.00
Última sincronização: 2023-05-23
Valor de mercado
$5.03M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Kyto Technology and Life Science, Inc. (KBPH)
Receita da Kyto Technology and Life Science, Inc. (KBPH)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Kyto Technology and Life Science, Inc., a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Kyto Technology and Life Science, Inc. de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$27.30B -
US
$16.04B -
US
- -
SE
$21.12B -
US
$5.40B -
US